LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.003
 36.73 770.25 2868 4086 0.7019 0.7265
MN20160304_L02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 36.73 770.25 2800 4086 0.6853 0.7094
MN20160304_L02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 38.95 770.25 2452 4543 0.5396 0.5718
MN20160304_L02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 38.95 770.25 3114 4543 0.6853 0.7256
MN20160304_L02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 38.95 770.25 2957 4543 0.6508 0.6911
MN20160304_L02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 41.17 770.25 2603 5010 0.5195 0.5695
MN20160304_L02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 41.17 770.25 3332 5010 0.6650 0.7197
MN20160304_L02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 41.17 770.25 3190 5010 0.6367 0.6922
MN20160304_L02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 43.39 770.25 2769 5404 0.5124 0.5765
MN20160304_L02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 43.39 770.25 3575 5404 0.6615 0.7266
MN20160304_L02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 43.39 770.25 3402 5404 0.6295 0.6964
MN20160304_L02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 45.61 770.25 3059 5813 0.5262 0.6048
MN20160304_L02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 45.61 770.25 3754 5813 0.6458 0.7215
MN20160304_L02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 45.61 770.25 3561 5813 0.6126 0.6906
MN20160304_L02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 47.83 770.25 3226 6223 0.5184 0.6083
MN20160304_L02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 47.83 770.25 3966 6223 0.6373 0.7223
MN20160304_L02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 47.83 770.25 3761 6223 0.6043 0.6923
MN20160304_L02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 50.05 770.25 3413 6629 0.5148 0.6150
MN20160304_L02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 50.05 770.25 4262 6629 0.6429 0.7348
MN20160304_L02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 50.05 770.25 4015 6629 0.6056 0.7018
MN20160304_L02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 52.27 770.25 3648 7058 0.5168 0.6268
MN20160304_L02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 52.27 770.25 4526 7058 0.6412 0.7404
MN20160304_L02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 52.27 770.25 4234 7058 0.5998 0.7044
MN20160304_L02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 54.49 770.25 3878 7555 0.5133 0.6334
MN20160304_L02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 54.49 770.25 4790 7555 0.6340 0.7416
MN20160304_L02
K07